A method for controlling two contaminants in a gas stream, comprising a system with two adsorption vessels, and analyzers for determining the concentration of the two contaminants is provided. The method includes purifying a gas stream with a first vessel placed in an adsorption mode and placing a second vessel in a standby mode. Then opening a second purge valve on the second vessel if the concentration of either contaminant is equal to or greater than predetermined threshold levels, thereby allowing a first portion of the purified gas exiting the first vessel to flow through the second vessel and exiting through the second purge valve. Then closing the second purge valve after a predetermined period of time when the concentration of both contaminants are less than or equal to a predetermined threshold level. Then switching the vessels and repeating the process.
Introduction: Medical air (MA) is widely used in hospitals, often manufactured onsite by compressing external ambient air and supplied through a local network piping system. Onsite production gives rise to a risk of impurities that are governed by the same pharmacopoeia purity standards applicable to commercially produced MA. The question to be addressed in this paper is how to assess if a lack of purity poses a medical problem? Methods: The MA produced onsite at a major Canadian hospital was monitored for carbon dioxide (CO2) and other impurity gases at high frequency (one per minute) over a two-month period. Results: The average CO2 concentration was 255 ppm. The United States Pharmacopeia (USP) threshold of 500 ppm was exceeded during 1% of the total study period, and the average while exceeding the threshold was 526 ppm. The maximum concentration was 634 ppm. Discussion and conclusion: To our knowledge, there is only one study that evaluated the effects suffered by respiratory patients of elevated nitric oxide in MA; thus, it is not clear what are the medical bases for the thresholds stated in the USP. To perform a Quality Risk Assessment, the threshold and the time above threshold should be considered in determining the frequency of sampling and analysis, and operating methods required to ensure the quality of MA entering the pipeline meets the clinical, regulatory, and patient safety standards. In conclusion, because the USP does not provide impurity thresholds for specific patients nor time above thresholds, there is a need for the medical community to determine these quantities before it can be known if the purity of MA is a problem.
The idea of engaging directly with management practice while retaining a strongly critical social science stance has become popular under the banner of critical performativity. This idea has yet to be applied to small firms, and it also needs specification: as usually stated, it lacks grounds within science to define with whom to engage and with what goals. In total, three themes are addressed: the nature of a radical pluralist' view of engagement, the distinct challenges in a small firm context and a set of three illustrations of possible lines of engagement. Engagement is both desirable and feasible, though large challenges remain, notably the demands of small-firm owners and the requirements of close engagement over a period of time.
A system and methods for printing and curing ink deposited on a substrate using a first light source and a second light source. In various embodiments, the first light source emits one or more wavelengths of electromagnetic radiation subtype C (UVC), and the second light source emits one or more wavelengths of electromagnetic radiation subtype A (UVA), subtype B (UVB), subtype V (UVV), or a combination thereof. The substrate is configured such that any ink deposited on the substrate by a printer head is predominantly exposed to the first light source prior to the second light source.
A radiation-curable ink composition for application to glass, ceramic, or metal by an inkjet printer. The ink composition can be applied to a glass, ceramic, or metal substrate to decorate, protect, etc. the substrate. In some embodiments, the ink composition includes a glass frits component, a chromophore component, and a UV-curable component. The glass frits component facilitates the fusing of the ink component with a glass, ceramic, or metal substrate to which the ink composition is applied. The chromophore component is the primary colorant of the ink composition. The UV-curable component facilitates activation of polymerization upon exposure to ultra-violet (UV) radiation, which causes the ink composition to cure and fix/pin to the underlying substrate. After the ink composition is applied to a substrate and cured by exposure to UV radiation, the substrate is heated to a temperature that causes the ink composition to fuse with the substrate.
As nurses, we have always had to develop and adapt as the world around us changes. The challenges we face, including an ageing population and a shortage of nurses, are vast, while the care we provide is increasingly complex.
The independent sector, with its range of career possibilities, doesn't always feature in nurses' career decisions, yet roles in this area can be extremely rewarding. So let's dispel some of the myths that hold nurses back from entering the private sector.
Graves, Caran
Faraklas, Iris
Maniatis, Katelynn
Panter, Elizabeth
La Force, Jessica
Aleem, Razia
Zavala, Sarah
Albrecht, Marlene
Edwards, Paul
Cochran, Amalia
Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe exfoliative diseases treated in burn centers due to large skin losses. Literature on SJS/TEN refers to parenteral nutrition (PN) as the preferred route of nutrition support. This study describes nutrition support interventions in SJS/TEN patients admitted to burn centers. Materials and Methods: Seven burn centers participated in this Institutional Review Board-exempted retrospective chart review of adults with SJS/TEN admitted from 2000-2012. Results: This analysis included 171 patients with SJS/TEN. Median total body surface area involvement was 35% (n = 145; interquartile range [IQR], 16%-62%). The majority required mechanical ventilation (n = 105). Based on indirect calorimetry, measured energy needs were 24.2 kcal/kg of admit weight (n = 58; IQR, 19.4-29.9). Thirty-one patients did not require enteral nutrition (EN) and started oral intake on hospital day 1 (IQR, 1-2), and 81% required EN support due to inadequate oral intake and remained on EN until day 16 (median hospital day, 16; IQR, 9-25). High-protein enteral formulas predominated. PN was rarely used (n = 12, 7%). Most patients were discharged home (57%), with 14% still requiring EN. Conclusions: Nutrition support should be considered in patients with SJS/TEN due to increased metabolic needs and an inability to meet these needs orally. Most SJS/TEN patients continued on EN and did not require escalation to PN.
The present invention relates to the field of analysis of the three-dimensional structure of the genome, i.e., for genome architecture mapping (GAM). The invention provides a method of determining spatial proximity of a plurality of nucleic acid loci in a compartment such as the cell nucleus, by exploiting their co-segregation amongst fractions of that compartment, identified upon separation of the nucleic acid loci from each other depending on their localization in the compartment to obtain a collection of fractions, e.g., by cryo-sectioning or cryo-milling the compartment; determining the presence or absence of the plurality of loci in said fractions; and determining the co-segregation of said plurality of loci. Co-segregation may then be analysed with statistical methods to determine spatial proximity. The method can be used e.g., for determining physical distance between a plurality of loci; and mapping loci and/or genome architecture, e.g., in the nucleus; identification of regulatory regions directing expression of a specific gene through spatial contacts; identifying the nuclear position of an exogenous nucleic acid in the nucleus and/or diagnosing a disease associated with a disturbed co-segregation of loci.